Novocure

The Christmas spirit has arrived in our Wayne, Pennsylvania Office! Our team had lots of fun wrapping presents donated to Connect Thru Cancer, a local non-profit organization providing free support services to individuals and families living with a cancer diagnosis. These presents ensure that families that have financial concerns due to a cancer diagnosis don’t go without gifts during the holiday season. At Novocure, we are committed to supporting patients, their caregivers, families and the communities where we live and work. #patientforward 

Novocure has announced positive topline results from Phase 3 PANOVA-3 clinical trial of Tumor Treating Fields (TTFields) Therapy in unresectable locally advanced pancreatic cancer. Read the press release here: https://lnkd.in/dMh_rWmj

Novocure has announced positive topline results from Phase 3 PANOVA-3 clinical trial of Tumor Treating Fields (TTFields) Therapy in unresectable locally advanced pancreatic cancer. Read the press release here: https://lnkd.in/dMh_rWmj

Novocure has announced positive topline results from Phase 3 PANOVA-3 clinical trial of Tumor Treating Fields (TTFields) Therapy in unresectable locally advanced pancreatic cancer. Read the press release here: https://lnkd.in/dMh_rWmj

Lung Cancer Awareness Month is coming to an end. Lung cancer is one of the most common causes of cancer-related death in North America. It’s a disease that deserves more awareness – every day of the year. At Novocure, we are proud to partner with the Lung Cancer Awareness Month Coalition to support patients and their caregivers, who are facing this disease every day. Together, let’s make a difference for them.

We are excited to be at the 2024 SNO Annual Meeting in Houston, Texas and look forward to connecting with the neuro-oncology community. If you are in attendance, consider stopping by the Novocure booth for the latest updates on Tumor Treating Fields (TTFields) therapy. Novocure will also sponsor a Lunch Independent Session on “The Impact of TTFields Therapy on Patient Outcomes – From Evidence to Practice”, on Nov 22, 12:45pm CST in Meeting Room 351 (Level 3).

At Novocure we are proud of our commitment to innovation and to announce the approval of our new Head Flexible Electrode (HFE) Transducer Arrays. We will also present new data at SNO 2024, the Society of Neuro Oncology Annual Meeting in Houston, Texas, from November 21-24. For more details, see our press releases: https://lnkd.in/e6gMu5xt https://lnkd.in/eUbQ9Qyh #SNO2024 #NeuroOncology #TTFields #ProductInnovation #Glioblastoma

Over 250,000 people get diagnosed with lung cancer in North America every year. November is Lung Cancer Awareness Month. Novocure is proud to partner with the Lung Cancer Awareness Month Coalition to increase the awareness of lung cancer and to support research that can improve outcomes for patients. Together, we can make a difference. Learn more here: https://lcam.org

What an inspiring day! We had the pleasure of hosting an incredible group of curious minds, aged 10-14, for a series of creative sessions at our office in Root, for National Future Day on November 14 in Switzerland, a nationwide event to broaden children’s horizons about various career paths. A big thank you to all the Novocure volunteers, speakers, and our amazing young participants for making this a very special day! The future is bright when young talents are empowered to explore, create, and dream big! #FutureDay #Zukunftstag #Switzerland #InspiringYouth #LearningForTheFuture

Each year, more than 125,000 people die from lung cancer in North America. November is Lung Cancer Awareness Month. Novocure is proud to partner with the Lung Cancer Awareness Month Coalition to increase the awareness of lung cancer and to support research that can improve outcomes for patients. Learn more here: https://lcam.org/ Together, we can make a difference.